The NIH has awarded a $3 million research grant to CND Life Sciences to initiate a 3-year multicenter study to evaluate the validity of a skin punch biopsy test to determine risk for Parkinson’s ...

Please provide your email address to receive an email when new articles are posted on . The Syn-One Test detected P-SYN presence in 75% of study participants during baseline evaluations. P-SYN ...

Could the key to detecting synucleinopathies be no more than skin-deep? In the March 20 JAMA, scientists led by Christopher Gibbons and Roy Freeman at Harvard Medical School in Boston detected ...

SCOTTSDALE, Ariz., Oct. 7, 2025 /PRNewswire/ -- CND Life Sciences, Inc. (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker ...

A 28-year-old woman visited her doctor about multiple lesions that developed on her back 2 months prior. On dermatologic examination, numerous round, atrophic, depressed plaques were seen on the back.

A mole is an unwanted skin growth. It usually looks like a flat or raised bump that’s the color of your skin or darker. Most people get moles as a teenager or adult. Some moles are present at birth.

The company plans to conduct a three-year study of Parkinson's risk among people with essential tremor, using its Syn-One Test.